Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,349 | 23 | 65.7% |
| Consulting Fee | $14,400 | 2 | 16.8% |
| Travel and Lodging | $12,099 | 32 | 14.1% |
| Food and Beverage | $2,719 | 55 | 3.2% |
| Honoraria | $150.00 | 1 | 0.2% |
| Education | $60.00 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $84,730 | 80 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $477.96 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $146.38 | 3 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $119.13 | 6 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $80.42 | 3 | $0 (2021) |
| Amicus Therapeutics, Inc. | $68.92 | 4 | $0 (2023) |
| Novo Nordisk Inc | $35.78 | 1 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $28.61 | 1 | $0 (2023) |
| Kyowa Kirin, Inc. | $25.85 | 1 | $0 (2024) |
| SPACELABS HEALTHCARE INC | $21.66 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,937 | 11 | GENZYME CORPORATION ($12,821) |
| 2023 | $29,125 | 37 | GENZYME CORPORATION ($28,910) |
| 2022 | $14,048 | 20 | GENZYME CORPORATION ($13,951) |
| 2021 | $13,844 | 17 | GENZYME CORPORATION ($13,512) |
| 2020 | $1,187 | 3 | GENZYME CORPORATION ($1,176) |
| 2019 | $6,201 | 15 | GENZYME CORPORATION ($5,945) |
| 2018 | $8,415 | 11 | GENZYME CORPORATION ($8,415) |
| 2017 | $20.68 | 1 | Alexion Pharmaceuticals, Inc. ($20.68) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| Category: Genetic Disease | ||||||
| 09/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Rare Disease | ||||||
| 08/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/21/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/13/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,007.00 | General |
| Category: Genetic Disease | ||||||
| 07/13/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $360.46 | General |
| Category: Genetic Disease | ||||||
| 07/13/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $38.48 | General |
| Category: Genetic Disease | ||||||
| 06/01/2024 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,185.00 | General |
| 04/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Rare Disease | ||||||
| 04/29/2024 | Tolmar, Inc. | FENSOLVI (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 01/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Rare Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Travel and Lodging | In-kind items and services | $540.50 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Travel and Lodging | In-kind items and services | $229.25 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Travel and Lodging | In-kind items and services | $147.38 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Food and Beverage | In-kind items and services | $133.89 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Food and Beverage | In-kind items and services | $69.63 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Food and Beverage | In-kind items and services | $51.59 | General |
| Category: Genetic Disease | ||||||
| 12/02/2023 | GENZYME CORPORATION | CERDELGA (Drug) | Food and Beverage | In-kind items and services | $49.15 | General |
| Category: Genetic Disease | ||||||
| 12/01/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug), BENLYSTA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEPHROLOGY | ||||||
| 11/27/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $107.14 | General |
| Category: Genetic Disease | ||||||
| 10/13/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| Category: Genetic Disease | ||||||
| 10/13/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $751.50 | General |
| Category: Genetic Disease | ||||||
| 10/13/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $404.67 | General |
| Category: Genetic Disease | ||||||
| 10/13/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | In-kind items and services | $162.64 | General |
| Category: Genetic Disease | ||||||
About Dr. Amy Becker, MD
Dr. Amy Becker, MD is a Pediatric Nephrology healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124037643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Becker, MD has received a total of $85,777 in payments from pharmaceutical and medical device companies, with $12,937 received in 2024. These payments were reported across 115 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,349).
Practice Information
- Specialty Pediatric Nephrology
- Location Corpus Christi, TX
- Active Since 08/05/2006
- Last Updated 10/28/2020
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1124037643
Products in Payments
- FABRAZYME (Biological) $58,431
- FABRAZYME (Drug) $14,360
- CERDELGA (Drug) $7,221
- ULTOMIRIS (Biological) $168.88
- Soliris (Drug) $150.00
- SOLIRIS (Drug) $145.68
- BENLYSTA (Biological) $128.25
- LUPKYNIS (Drug) $119.13
- Crysvita (Drug) $46.27
- GALAFOLD (Drug) $30.89
- OXLUMO (Drug) $28.61
- JESDUVROQ (Drug) $18.13
- Qbrelis (Drug) $18.05
- Ultomiris (Drug) $13.40
- FENSOLVI (Drug) $13.33
- Epaned (Drug) $11.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Nephrology Doctors in Corpus Christi
Dr. Samhar Al-Akash, M.d, M.D
Pediatric Nephrology — Payments: $26,283
Dr. Franca Tilley-Gyado, M.d, M.D
Pediatric Nephrology — Payments: $1,237
Fredrick Mccurdy, Md, Phd, Mba, MD, PHD, MBA
Pediatric Nephrology — Payments: $788.70
Dr. Salam Gharaybeh, M.d, M.D
Pediatric Nephrology — Payments: $560.88
Dr. William Allen, M.d, M.D
Pediatric Nephrology — Payments: $155.12